(Date:11/29/2009)...ewswire/ -- Acuo Technologies, developers of high-...a migration tools and services, today announced a ...image sharing across the networks of hospitals, cl...on is based on the versatile Acuo Technologies DIC... enables secure access from various PACS to medica...
(Date:11/29/2009)...sts urine production, experts say , , S... up during the night to urinate shouldn,t automati...reathing-related sleep disorder, could be the caus...ion, or nocturia, is comparable to loud snoring as...in which soft tissue in the throat blocks the flow...
(Date:11/28/2009)... -- Welcome to syngo® .plaza(1), the ... from Siemens Healthcare. As the first Picture... Siemens where 2D, 3D, and 4D reading come togethe...nge the way multimodality images are read today. S...Scientific Assembly and Annual Meeting of the Radi...
(Date:11/28/2009)...ct circadian rhythm, , , FRIDAY, No...at an internal body clock that goes on the fritz c...order in children. , The finding results from ...ren with bipolar disorder, which can make people s...without the disorder. They linked variations in a ...
(Date:11/27/2009).../ - Uploadable USB pedometers may be new, but they...nation of advanced accelerometer functionality and...cern over the accuracy of self-reported data. It,s...ved participation in a fitness program. ,, Core...uppliers to integrate this technology. "Our health...
Breaking Medicine News(10 mins):Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:New USB technology adds accountability and convenience to wellness programs 2...Topp Twins, well known entertainment duo, has been...pp, 48, one of the duo with her sister Lynda, is r...erapy treatment during the next few weeks.
Topp... breast lumps checked immediately and her prompt a...
...lled Rosiglitazone capable of controlling Type 2 d...hers, Researchers// content that this drug is capa...h medical journal . Researchers content that this ...ion )conducted at Royal Victoria Hospital led by e...
...a recent study, kids with bigger heads tend to be ...
This study conducted by Catherine Gale, Ph.D....ssue of the journal Pediatrics.
633 full-term ...4 and 8years.
The kids took IQ tests at the ...
... prevention office of the Ministry of Health relea... Blind, according to which//, around 45,000 new ca...ina.
"By July, China has reported 12 million p...office in East China's Shandong Province.
Acco...
...rage commercial banking of umbilical cord blood. O...e to public// blood banks without the motive of fi...th stem cells are beneficial in treating diseases ...ely easy to obtain. Also cord blood is not known t...
...rus appears to be fast engulfing Uttar Pradesh's c...ay.
"Of the 31 dengue-positive cases admitted... affected districts,// 20 were from Lucknow alone,... past four days, taking the tally to 97 in Lucknow...
Other Medicine News:Health News:New drug proven to tackle Type 2 Diabetes 2Health News:Baby’s Head Growth influences its Intelligence 2Health News:NHS Will Do Well to Curb Use Of Umbilical Cord Blood For Treatment of Cancers 2...TA, Sept. 24 Alimera Sciences, Inc., a privately,... the research,development and commercialization of...ported that after completing its review of safety,...ent Data Safety,Monitoring Board (DSMB) has again ...trials for the use of Iluvien(TM) in the treatment...
...OLIS, Md., Sept. 24 PharmAthene, Inc.,(Amex: PIP...rmeasures,against biological and chemical threats,...o posters and an oral presentation on its medical,...Valortim(R) at the HHS,Public Health Emergency Med...ers Workshop 2008 / BARDA Industry Day being held ...
Other Medicine Technology:DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME 2DSMB Again Supports Continuation of Alimera Sciences' Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME 3PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop 7...NS272 is a fully featured Peripheral Nerve Stimula...omuscular blocks during surgery or intensive care ...anesthesia. , ,The constant current NS232, NS252,...rammed. ,Hand-held, battery operated, and includes...
EZStim™II
TR 5000 Tourniquet Systems
TR 4500 Tourniquet Systems
Medicine Products: